Literature DB >> 31212130

Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.

Gang Li1, Meng Wang2, Liangliang Ren3, Hanzong Li4, Qinghua Liu2, Ying Ouyang2, Lixin He2, Fengyan Li5.   

Abstract

BACKGROUND: Bladder cancer is a complicated disease with high rate of morbidity and mortality, in which proliferation and migration are both well acknowledged as aggressive phenotypes of bladder cancer cells. A better understanding of the mechanisms of tumor proliferation and migration would provide an insight into cancer progression and provide effective therapeutic strategies.
METHODS: The expression of RGS20 was detected using qRT-PCR,western blotting and immunohistochemistry. MTT, Colony formation, anchorage-independent growth assay, and transwell assay were used to evaluate the pro-proliferation and pro-migration potential of RGS20 in vitro. Tumor growth was monitored and analyzed in an animal model. Luciferase activity assay, nuclear extract analysis, and multiple blockade of NF-κB were used to evaluate NF-κB signaling activity.
RESULTS: It revealed that RGS20 was significantly upregulated in bladder cancer and increased RGS20 expression correlated significantly with worse 5-year overall survival. Ectopic overexpression of RGS20 accelerated the proliferation and migration of bladder cancer cells, whereas knockdown of RGS20 inhibited these effects. Mechanistically, RGS20 could activate NF-κB signaling, which played a crucial role in RGS20's effects on proliferation, migration, and tumorigenicity of bladder cancer cells.
CONCLUSION: Our study highlights that RGS20 acted as an oncogene in bladder cancer and a better understanding of RGS20's functions might provide the potential for clinical intervention in this disease.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Bladder cancer; Migration; NF-κB signaling; Proliferation; RGS20

Year:  2019        PMID: 31212130     DOI: 10.1016/j.biopha.2019.109112

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.

Authors:  Kun Li; Tongyue Yao; Yu Zhang; Wen Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

2.  Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer.

Authors:  Yue Liu; Weiming Lou; Guang Chen; Bing Ding; Jin Kuang; Yize Zhang; Cong Wang; Sainan Duan; Ying Deng; Xiongbing Lu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer.

Authors:  Dazun Shi; Shiyu Tong; Hui Han; Xiheng Hu
Journal:  J Oncol       Date:  2022-04-19       Impact factor: 4.375

4.  Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma.

Authors:  Yulu Wang; Maria F Setiawan; Hongde Liu; Tikam Chand Dakal; Hongjia Liu; Fangfang Ge; Oliver Rudan; Peng Chen; Chunxia Zhao; Maria A Gonzalez-Carmona; Miroslaw T Kornek; Christian P Strassburg; Matthias Schmid; Jarek Maciaczyk; Amit Sharma; Ingo G H Schmidt-Wolf
Journal:  Biology (Basel)       Date:  2022-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.